EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome

BACKGROUND: Despite the advances in glioblastoma (GBM) treatment, the average life span of patients is 14 months. Therefore, it is urgent to identity biomarkers of prognosis, treatment response, or development of novel treatment strategies. We previously described the association of high epidermal g...

Descripción completa

Detalles Bibliográficos
Autores principales: da Costa, Bruno Henrique Bressan, Becker, Aline Paixão, Neder, Luciano, Gonçalves, Paola Gyuliane, de Oliveira, Cristiane, Polverini, Allan Dias, Clara, Carlos Afonso, Teixeira, Gustavo Ramos, Reis, Rui Manuel, Bidinotto, Lucas Tadeu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists/The Korean Society for Cytopathology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288890/
https://www.ncbi.nlm.nih.gov/pubmed/35698739
http://dx.doi.org/10.4132/jptm.2022.04.22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288890/
https://www.ncbi.nlm.nih.gov/pubmed/35698739
http://dx.doi.org/10.4132/jptm.2022.04.22

Ejemplares similares